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Abstract
The erythrocyte contributes to the immune system in several ways. It 
sequesters interferons, interleukins or chemokines and by binding nucleic acid. 
It binds virus and bacteria and may deliver bacteria to macrophages for phago-
cytosis. It may also kill bacteria directly with oxygen. For proper function of the 
erythrocyte, homeostasis of reactive oxygen species, selenium, metal ions and 
trace elements is important. Erythrocytes display morphological and metabolic 
changes in diseases like sepsis, and in several genetic diseases. Patients infected 
with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), giving 
rise to the coronavirus disease 2019 (Covid-19), show many erythrocyte changes 
as compared to healthy controls. The erythrocyte responds to hemolysins by 
purinergic signaling leading to hemolysis or phosphatidylserine exposure on 
the plasma membrane. Phosphatidylserine marks erythrocytes for clearance 
by spleen macrophages. Regulated erythrocyte cell death, also called eryptosis, 
can be induced by oxidative stress, pathogen infection, and certain diseases like 
sepsis. Erythrocytes may, in the future, contribute more to diagnosis based on 
research and diagnostic technological development.
Keywords: Erythrocyte, cytokine, sepsis, reactive oxygen species, selenium, iron, 
calcium, metal ions, ICP-MS, hierachy, Covid-19
1. Introduction
Recent research has shown that the erythrocyte contributes in many ways to 
defense against pathogens. The human erythrocyte is infected by the unicellular 
eukaryotic parasites Plasmodium and Babesia and the bacterium Bartonella [1]. 
Bacteria may adhere to glycosylated erythrocyte membrane proteins thereby 
facilitating phagocytosis by macrophages. Bacteria adhering to the erythrocyte 
surface may also be killed by oxygen release [2]. The erythrocyte also reacts 
with morphological changes to infections like Covid-19 or a disease like sepsis. 
However, the mammalian erythrocyte, having lost its nucleus and organelles, 
seems to play less a role in the immune system than erythrocytes of fish and birds 
[3]. The chapter will review aspects of mainly human erythrocytes in immunol-
ogy and homeostasis with some special attention given to the ongoing Covid-19 
pandemic.
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2. The erythrocyte in immunology
Erythrocyte surface antigens play an important role in the erythrocyte interac-
tion with pathogens and in other immune reactions. To begin with, the Duffy 
antigen has been found to be the entry point for Plasmodium vivax. This is sup-
ported by the finding that Duffy-negative individuals have some protection against 
P. vivax infection. Duffy negativity is common in the African population, although 
P. vivax may be able to infect some Duffy negative individuals [4]. Duffy was found 
to be a receptor of the chemokine with Cysteine-X-Cysteine (C-X-C) motif ligand 8 
(CXCL8, also called interleukin-8) (Figure 1), and other chemokines such as 
chemokine with Cysteine-Cysteine (C-C) motif ligand 2 (CCL2, also called macro-
phage chemoattractant protein-1 (MCP-1)) were later also found to bind to Duffy 
[5]. The Duffy protein is a putative G-protein coupled receptor, but lacks some parts 
that would be necessary for signaling and is therefore regarded as a non-signaling 
receptor. The current hypothesis is that Duffy functions as a buffer-storage-sink for 
chemokines in the body. One indication for this is the reduced neutrophil counts 
and increased risk of acquiring human immunodeficiency virus (HIV-1) that has 
been found in Duffy-negative individuals [6]. However, overall neutrophil effector 
functions were largely unaffected in HIV-1-infected and non-infected Duffy-
negative individuals [7]. One explanation for this could be an increased proteolytic 
activity as a compensatory mechanism for lower absolute neutrophil counts [7].
Chemokines belong to a group of immune signaling proteins called cytokines. In 
addition to chemokines, interferons, interleukins and the hormone erythropoietin 
are classified as cytokines. From the initial discovery of chemokine binding to 
Duffy, many more cytokines have been shown to be associated with the erythrocyte 
[8]. A considerable step forward was taken in a study where almost 50 different 
cytokines were identified in erythrocyte preparations [9]. Among chemokines, 
several from the C-C and the C-X-C families were found. Among interleukins, 
the interleukin-1, interleukin-6, interleukin-12 and interleukin-17 families were 
present (Figure 1). Present were also granulocyte-macrophage colony stimulating 
factor (GMCSF), interleukin-3, interleukin-5, tumor necrosis factor (TNF) super-
family and platelet derived growth factor (PDGF) (Figure 1). Interferon type I was 
represented by interferon-alpha2 whereas interferon type II was represented by 
interferon-gamma (Figure 1). The study suggests that the erythrocyte has signifi-
cant capacity to contribute to the cytokine pool and immune homeostasis.  
Figure 1. 
Schematic figure of the erythrocyte in immunology. An erythrocyte contains 1.2 million band3 and 0.5 million 
glycophorin a molecules. Abbreviations are explained in the text.
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In addition, cytokine and cytokine receptor gene expression has been found in both 
human and murine erythroblasts [10, 11].
Most of the cytokines have been localized extracellularly on the erythrocyte 
possibly bound to transmembrane receptors or associated to the glycocalyx. 
Macrophage migration inhibitory factor 1 (MIF1), D-dopachrome tautomer-
ase (DDT) and interleukin-33 were found to have an intracellular localization 
[8, 12] (Figure 1). Interleukin-33 is a nuclear localized interleukin belonging to 
the interleukin-1 family [12]. Interleukin-33 is probably left over after expelling 
of the nucleus from the reticulocyte. MIF1 and DDT were found to exist in the 
erythrocyte, although the exact receptor has not been identified. In other tissues, 
a receptor for MIF1 and DDT is formed by CD74 and the hyaluronan receptor 
CD44 (Figure 1), which is also present on erythrocytes [13]. Intracellular as well 
as extracellular erythrocyte cytokines may be released by hemolysis or in protein-
containing micro-vesicles or micro-particles produced by the erythrocyte [14–16].
Toll-like receptors (TLR) are a group of trans-membrane receptors of the innate 
immune system. TLR9 was shown to be present on erythrocytes [17] (Figure 1), 
although not all erythrocytes express TLR9 and considerable interindividual differ-
ences in expression was found [17]. Presence of mitochondrial but not nuclear DNA 
was confirmed on human and mouse erythrocytes. A knock-out mouse for TLR9 
lost much of the mitochondrial DNA binding capacity otherwise found on human 
and mouse erythrocytes. TLR9 protein was mainly localized in the erythrocyte 
close to the plasma membrane probably binding to band3, a 14-transmembrane 
helices protein also known as anion exchanger 1 (AE1 or SLC4A1). Some evidence 
was found for erythrocyte scavenging of mitochondrial DNA from microvascular 
endothelial cells [17]. The erythrocyte may also interact with macrophages through 
the TLR9 receptor [18] (Figure 1). Additional TLRs may also exist in the erythro-
cyte, since expression of several TLRs was found in murine erythroblasts [11].
Erythrocytes also store and export the multifunctional molecule sphingosine-
1-phosphate (S1P) (Figure 1). Inside the erythrocyte S1P has been shown to 
be involved in regulation of glycolysis [19]. S1P binds the S1P-receptor-1 on 
lymphocytes, antagonizing their egress from secondary lymphoid organs and 
the thymus. When bound to apolipoprotein M, S1P reduces lymphopoiesis by 
binding S1P-receptor-1 on common lymphoid progenitors in the bone marrow 
[20]. Erythrocytes synthesize S1P from sphingosine obtained from plasma in a 
reaction catalyzed by sphingosine-kinase-1. Because of lack of cellular organelles 
and their associated enzymes, no S1P-degrading enzyme is present in erythrocytes. 
These therefore effectively function as a S1P storage facility. Through site-directed 
mutagenesis and gene-knock-out studies, the major facilitator superfamily domain 
2b (Mfsd2b) was found to be the exporter of S1P from erythrocytes [21]. Export 
of S1P from erythrocytes (Figure 1) was inhibited by an anion transport inhibitor, 
suggesting that also band3 may be involved in S1P export [22]. Erythrocytes are 
considered the major source of S1P plasma levels because of low plasma S1P levels 
in anemic patients. S1P plasma levels are also regulated by the lipid phosphate 
phosphatases, LPP1 and LPP3, on the plasma membrane of endothelial cells [23]. 
In addition, S1P levels in plasma may also depend on the presence and regulation of 
S1P carrier molecules like albumin and apolipoprotein M in complex with high-
density lipoprotein.
Important for entry of P. falciparum into the erythrocyte are glycophorin 
A, band3, complement receptor 1 (CR1) and basigin [24] (Figure 1). Basigin is 
also known as the extracellular matrix metalloproteinase inducer (EMMPRIN) 
or CD147. The protein glycosylation underlying the ABO blood group system, is 
present on erythrocyte membrane proteins like band3. The ABO glycosylation is 
used by Plasmodium to facilitate rosetting, a stage in Plasmodium pathogenesis [25]. 
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Blood group O favors rosetting less than the A or B blood groups. Interestingly, the 
same pattern can be seen in Covid-19, where blood groups A or B are risk fac-
tors, whereas group O appears to be comparatively protective [26]. Glycophorin 
A is the most abundant sialo-glycoprotein on erythrocytes (Figure 1). Sialic acid 
residues are often used as receptors for invasion by bacteria and other pathogens 
[27] (Figure 2). Sequence analysis of glycophorin A from several primate species 
revealed high diversifying selection in the glycophorin A gene [27]. High selective 
pressure could be explained as a consequence of targeting of different pathogens 
by the glycophorin A receptor. This led to the pathogen decoy hypothesis, which 
states that the erythrocyte functions as a “flypaper”, using glycophorin A to bind 
pathogens [27]. Pathogens may then be cleared by macrophages as erythrocytes 
pass through the spleen.
3. The erythrocyte and virus
The erythrocyte does not contain a nucleus or other organelles necessary for 
virus replication and survival. Its interaction with viruses is therefore mainly 
restricted to adherence of virus to the plasma membrane, transmembrane proteins 
or glycocalyx carbohydrates like sialic acid (Figure 2). Erythroid progenitor cells 
may however be infected with parvovirus B19 [28] which may lead to anemia. The 
ongoing Covid-19 pandemic has renewed interest in erythrocyte-virus interactions, 
due to the hypoxia or acute respiratory distress syndrome (ARDS) often seen in 
the disease [29]. Erythrocytes from Covid-19 patients showed increased protein 
degradation and glycolysis [29]. Increased or decreased levels of many lipids were 
seen [29]. Some signs of oxidative stress was noted, such as increased oxidized glu-
tathione and increased protein levels of peroxiredoxin 2. Interestingly, N-terminal 
oxidation or degradation of band3 was noted (Figure 2). The cytosolic, N-terminal 
part of band3 has been shown to be of importance in signaling and hemoglobin 
regulation [30] and its oxidation or degradation may therefore explain some of 
Figure 2. 
Schematic figure of the erythrocyte and its interactions with viruses. Adenovirus and parvovirus lack a lipid 
bilayer around the virus capsid. Covid-19 disease affects the erythrocyte without entry of SARS-CoV-2 into the 
erythrocyte. Abbreviations are explained in the text.
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the other noted effects of SARS-CoV-2 on the erythrocyte (Figure 2). Based on 
metabolic and molecular pathway analysis [29], protein degradation pathways, such 
as proteasome and ubiquitinylation components were identified as significantly 
affected in erythrocytes of Covid-19 patients (Figure 2). In addition, effects were 
noted on ferroptosis, cyclic-adenosine monophosphate (cAMP) and AMP-activated 
protein kinase signaling cascades. Lipid metabolism was also affected, especially 
acyl-carnitine and sphingolipid metabolism [29]. The effect on ferroptosis was 
based mainly on increased levels of peroxidated lipids and increased levels of heat 
shock protein beta-1, which inhibits ferroptosis by reducing intracellular levels of 
iron and maintaining levels of reduced glutathione [31]. The precise mechanism 
may be through inhibition of transferrin-receptor mediated iron uptake via stabi-
lization of the cytoskeleton [31]. Ferroptosis is an iron-dependent non-apoptotic 
version of regulated cell death. It is caused by increased levels of iron accompanied 
by reduced activity of the selenium-dependent enzyme glutathione-peroxidase 4 
and mitochondrial changes such as reduced mitochondrial size and mitochondrial 
membrane rupture. Protein levels of glutathione peroxidase 4 were unchanged 
in erythrocytes of Covid-19 patients [29]. The absence of mitochondria in the 
erythrocyte would argue against the existence of ferroptosis in the erythrocyte. 
In the Covid-19 infected patients, there were no alterations of directly clinically 
relevant hematological parameters, such as erythrocyte count, hematocrit, or mean 
corpuscular hemoglobin concentration [29]. The reason for hypoxia or ARDS in 
Covid-19 patients may therefore not be found in the erythrocyte, possibly with 
exception of the severe hypoxia without impaired lung function that has been seen 
in some patients [32]. Respiratory failure is the most common direct cause of death 
in Covid-19 patients [33, 34]. Studies have reported the nuclear remnants called 
Howell-Jolly bodies, or seemingly fully nucleated erythrocytes in Covid-19 patients 
[35, 36]. Nucleated erythrocytes indicate a bad prognosis and often occurs in 
critically ill patients in several diseases [37]. Mortality risk in Covid-19 seems to be 
associated with higher erythrocyte distribution width (RDW), a measure of hetero-
geneity of erythrocyte volume (Figure 2). In a meta-analysis of Covid-19 patients, 
higher RDW was associated with more severe disease [38]. The precise reason for 
this is unknown, but may involve reduced erythropoiesis or impaired erythrocyte 
clearance. A more prominent role of erythrocytes in the disease progression can 
therefore not be ruled out. For instance, in post-mortem analysis of Covid-19 
patients with kidney injury, intact erythrocytes were found obstructing peritubular 
and glomerular capillary lumens [39]. A study of blood samples from Covid-19 
patients showed depletion of several immune factors, among them interferon-alpha 
[40], an interferon that was previously localized in erythrocytes [9]. However, 
erythrocyte cytokine levels have so far not been analyzed in Covid-19 patients. 
Anemia in Covid-19 patients may be related to the increased interleukin-6 levels 
(Figure 2) that have been reported in the disease [41]. Interleukin-6 downregulates 
the iron exporter ferroportin via hepcidin [42]. Lower ferroportin activity makes 
iron stored in macrophages less available for erythropoiesis and for existing eryth-
rocytes [43, 44]. Increased levels of interleukin-6 have also been implicated as being 
responsible for the cytokine release syndrome seen in some Covid-19 patients, 
particularly those affected by ARDS or severe hypoxia [41, 45]. The interleukin-6 
receptor blocker tocilizumab showed disappointing results in Covid-19 patients 
[46, 47] suggesting a more complex pathophysiology of cytokine release syndrome 
in Covid-19 patients. In HIV-1 patients, anemia often appears together with second-
ary infections or nutritional deficiencies [44, 48], or is caused by treatment with 
zidovudine, which is a known cause of bone-marrow suppression [48]. Reduced 
erythropoietin levels in HIV-1-related anemia may have been caused by upregula-
tion of proinflammatory cytokines like interleukin-1-beta and TNF-alpha [49] or by 
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autoantibodies to erythropoietin [50]. HIV-1 may infect hematopoietic progenitor 
cells, but this is not considered a critical cause of anemia in HIV-1 patients [51].
Using biophysical modeling, band3 was suggested to be the point of attachment 
for SARS-CoV-2 on the erythrocyte surface [32]. The oxidation or degradation 
noted in band3 [29] may therefore have been caused directly by the binding of the 
virus. It should be noted that no entry of SARS-CoV-2 into the erythrocyte has as 
yet been proven (Figure 2). The effect of the virus on the erythrocyte may hence 
be due only to binding to surface receptors. The angiotensin-converting enzyme 2 
(ACE2) membrane protein that is considered necessary for entry does not occur in 
erythrocyte membranes according to the erythrocyte proteome database (http://
rbcc.hegelab.org/) [52], making ACE2 an unlikely entry or attachment point for 
SARS-CoV-2 on the erythrocyte surface [32]. Basigin, one of the erythrocyte recep-
tors for P. falciparum, is not considered a receptor for SARS-CoV-2 [53], although 
such claims have been advanced [54]. The differential susceptibility conferred by 
the ABO blood group system to Covid-19 may imply a participation of the ABO gly-
cosylation in attachment of the virus to the erythrocyte or other cells [26]. Band3, 
the suggested erythrocyte attachment protein for SARS-CoV-2, contains ABO 
glycosylation on the N-642 asparagine residue in the extracellular loop between 
transmembrane helices TM7 and TM8 [30]. This does not by itself necessarily imply 
involvement of the erythrocyte in Covid-19 pathogenesis since the ABO blood 
group system is expressed also on other membrane proteins and in other cells in 
the human body [55]. In contrast, the ABO blood group system seems not to be of 
importance for infection by the HIV-1 virus [56].
The erythrocyte has been suggested to be a hiding place for viruses, although 
these would not be able to infect the erythrocyte. Adsorption to erythrocytes has 
been shown for HIV-1, influenza and adenovirus [57–59] (Figure 2). Zika virus has 
been shown to survive in erythrocyte samples [60]. Zika virus could be detected in 
erythrocytes for a significantly longer time than in serum. Considering the ongoing 
SARS-CoV-2 pandemic, it would be of interest for applied transfusion and blood 
bank science to know the persistence of the SARS-CoV-2 virus on erythrocytes.
4.  Erythrocyte selenium, metal ion and trace element status in relation 
to virus exposure
Metal ions, trace elements and other compounds contribute in different hier-
archies to complex reactions that maintain blood homeostasis (Figure 3) [61]. 
Erythrocyte redox homeostasis is maintained through ascorbic acid, superoxide 
dismutase, catalase, glutathione and glutathione peroxidase. Antioxidant activity 
of selenium-dependent glutathione peroxidase may protect band3 of erythrocytes. 
Selenium is therefore important even for the basic oxygen and carbon dioxide 
exchange performed by the erythrocyte. Selenium as organic or inorganic form 
is metabolized by erythrocytes, platelets and neutrophils in different ways [62]. 
In one study, selenium was supplied together with plain food as inorganic sodium 
selenite at 200 microgram/day for one year. Neutrophils accumulated selenium 
more than platelets followed by erythrocytes [62]. In a similar study where selenium 
was supplied as 1-selenomethionine at 50 microgram/day for one year, platelets 
accumulated most selenium followed by erythrocytes and neutrophils [63]. These 
observations indicate that different cells metabolize inorganic and organic forms 
of selenium differently. The absence of nucleus and organelles in erythrocytes 
may partly explain the difference. Selenium supplied as inorganic sodium selenite 
was associated with decreased iron concentration in platelets and neutrophils. 
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This result may indicate an iron-regulating function of selenium which may be 
particularly relevant for the erythrocyte considering its high iron content. Analysis 
of selenium and other elements was performed by micro-PIXE (micro-particle 
induced X-ray emission). Increased levels of Cd, Pb and Ag were reported in a 
study of erythrocytes in patients with Alzheimer’s or Parkinson’s disease, using 
the more sensitive and selective ICP-MS (inductively coupled plasma mass 
 spectrometry) [61].
In view of these observations it is interesting that Covid-19 patients with higher 
selenium and selenoprotein P levels had lower mortality risk [64]. A correlation 
has also been found between cure rate and hair selenium concentration in Chinese 
Covid-19 patients [65]. As virus bind to erythrocytes, virus can be transported to 
different organs e.g. lung, kidney and brain. Viral particles may then find their way 
through the blood–brain-barrier or enter through the choroid plexus, an important 
part of the brain filtration system. The SARS-CoV-2 virus may decrease oxygen sup-
ply when attached to erythrocytes and impair brain oxygen supply. Low selenium 
intake may worsen the disease progress.
Erythropoiesis is partly regulated by microRNA and dependent on a high 
selenium status [66]. For instance, using a mouse loss-of-function allele, 
microRNA-142 was found to be required for maintaining typical erythrocyte shape, 
for normal metabolism of reactive oxygen species, and for overall erythrocyte 
lifespan [67]. MicroRNAs are differentially expressed depending on selenium status 
[68]. However, a precise role of selenium in regulating microRNA in relation to 
erythropoiesis has not been described. In addition, mechanisms underlying much 
of microRNA function are still not fully understood.
Figure 3. 
The flow of compounds and metal ions between cells is dependent on the three main chemical pathways in a 
hierarchy. The first path involves free radical-induced production of compounds where hydroxyl radical and 
solvated electron reactions may be involved. The second path involves electrophilic and nucleophilic compounds 
forming products adequate to the cells. The third path involves metal ions and ligands dependent on the 
previous two pathways but adapted to cell demand. In erythroid precursors and in other cells, excluding the 
erythrocyte, compounds and metal ions may reach DNA and RNA not controlled by evolutionary developed 
genome adapted to cell demand. Small changes of DNA and RNA may take place, an epigenetic change, which 
may be restored or adapted, but large damages will present symptoms and are difficult to restore.
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5. The erythrocyte and reactive oxygen species
Reactive oxygen species (ROS) are a set of oxygen containing compounds 
that easily react with and damage other constituents of the cell. Typical ROS in 
biological systems are superoxide, hydrogen peroxide and hydroxyl radical. ROS 
can be thought of as forming a hierarchy in the living organism (Figure 3). In the 
erythrocyte, superoxide is produced when Fe(II) of hemoglobin donates an electron 
to an oxygen molecule, generating the anionic superoxide and the oxidized Fe(III). 
This reaction is unavoidable due to the existence of iron and oxygen in close contact 
in the erythrocyte [69]. Superoxide can also be generated in the erythrocyte by 
nitric oxide synthase, an enzyme identical to the endothelial nitric oxide synthase 
(e-NOS). The superoxide is converted to water and hydrogen peroxide by copper 
and zinc-dependent superoxide dismutase. Hydrogen peroxide needs to be further 
metabolized to avoid the Fenton reaction which otherwise would generate the 
hydroxyl radical, a very reactive form of ROS. To defuse hydrogen peroxide the 
erythrocyte contains several enzymes, the most important being catalase, peroxire-
doxin 2 and glutathione peroxidase 4. Peroxiredoxin 2 is one of the most abundant 
proteins in the erythrocyte cytosol [70]. In the oxidized form, peroxiredoxin 2 is 
recycled by thioredoxin using reduced nicotinamide adenine dinucleotide phos-
phate (NADPH) and thioredoxin reductase. Peroxiredoxin 2 is suggested to func-
tion as a non-catalytic scavenger of low-level hydrogen peroxide generated from 
autoxidation of hemoglobin [71]. However, a fraction of peroxiredoxin 2 is found 
attached to the erythrocyte plasma membrane and may be particularly important in 
detoxifying membrane lipid peroxides [72]. Catalase and the selenium-dependent 
glutathione peroxidase are important for the detoxification of hydrogen peroxide 
received by the erythrocyte from other parts of the vascular compartment. In 
plasma, superoxide is generated by xanthine oxidase, NADPH oxidase and nitric 
oxide synthase [73], enzymes that can occur in association to glycosaminoglycans 
of the endothelial cells of the vascular wall. Superoxide generated by these means 
can enter the erythrocyte by anion channels like band3. Alternatively, superoxide 
in plasma may be converted to hydrogen peroxide by extracellular superoxide 
dismutase. Hydrogen peroxide can then enter the erythrocyte by diffusion through 
the plasma membrane. Under stress conditions the erythrocyte receives much ROS 
generated by other cells inside or outside of the vascular compartment. Such ROS 
may have been generated by mitochondrial stress as a result of bacterial and viral 
infections (Figure 3). For instance, mitochondrial generation of ROS has been 
proposed as an important part of Covid-19 disease [74]. Antioxidant defense in 
erythrocytes also depends on small-molecule antioxidants like alpha-tocopherol, 
glutathione, ascorbate and reductants like NADPH generated in the pentose phos-
phate pathway. Alpha-tocopherol is present in erythrocyte plasma membrane where 
it may prevent lipid peroxidation. Glutathione participates as reductant in enzyme-
catalyzed reactions. Ascorbate then recycles oxidized forms of alpha-tocopherol 
and glutathione back to the reduced forms. Superoxide can also react with nitric 
oxide generating peroxynitrite, a reactive nitrogen species [73]. The extent to which 
this reaction occurs depends on the presence of nitric oxide inside the erythrocyte. 
Nitric oxide is produced by nitric oxide synthase but also scavenged by oxyhemo-
globin in the erythrocyte. Peroxynitrite can also be formed in plasma and may enter 
the erythrocyte as anion through band3. In conditions of stress, such as infection 
with SARS-CoV-2, ROS overload damage the erythrocyte plasma membrane which 
can lead to hemolysis. The necessity of the antioxidant system of erythrocytes has 
been proven in gene knock-out studies in mice. For instance, deletion of perox-
iredoxin 1 or peroxiredoxin 2 led to increased plasma ROS, hemolytic anemia and 
shortened life and erythrocyte lifespan [75, 76].
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6. The erythrocyte in sepsis
Sepsis is a strong and dysfunctional inflammatory response to an infection. In 
later stages it proceeds to immunosuppression, decreased pro-inflammatory cyto-
kine levels and increased apoptosis of immune cells. The immunosuppressed stage 
can last for many months or even years and comes with increased risk for death due 
to secondary infections. Many aspects of sepsis have been highlighted recently like 
the presence of exosomes [77], complement and histones [78], metabolic changes 
[79] and ROS and inflammasomes [80]. Gene expression analysis of sepsis patients 
revealed CXCL8, tumor protein P53 and TNF as particularly important based on a 
subsequent pathway analysis [81, 82]. The chemokine CXCL8 binds to chemokine 
receptors on neutrophils, ultimately leading to attachment of neutrophils at sites 
of infection. Neutrophils have an important function in phagocytosis of bacteria 
through neutrophil extracellular traps (NET). Analysis of plasma protein levels of 
sepsis patients identified the cytokines interleukin-17 and interleukin-27 as being 
elevated early in sepsis, whereas interleukin-33 protein levels increased later in 
the immunosuppressive phase [83]. The three interleukins form an axis in sepsis 
pathophysiology with interleukin-27 having a inhibitory effect on the proinflamma-
tory interleukin-17. The effect of interleukin-27 on interleukin-33 may depend on 
the stage of disease. Interleukin-33 has been shown to improve survival in murine 
sepsis models, which can be explained by increased neutrophil presence and more 
bacterial clearance at the site of infection. Interleukin-33 may have a protective 
effect by rebalancing different types of immunity [83]. Interleukin-33 has also been 
reported to suppress and modulate lymphocytes of the innate immune system such 
as type 2 innate lymphoid cells [84], and induce regulatory T cells. The contribu-
tion of erythrocytes to the pool of cytokines in sepsis has not been investigated. 
However, some of the cytokines implicated in sepsis pathophysiology like interleu-
kin-17, interleukin-33 and CXCL8 have been reported to occur on erythrocytes from 
healthy individuals [9]. Pathophysiology of sepsis in individuals negative for the 
CXCL8 receptor Duffy or Duffy knock-out mice has not been reported. Apoptosis 
is a contributing factor to immunosuppression in sepsis [85]. A first hint of this 
was the finding that overexpression of B-cell lymphoma 2 (Bcl-2) protected against 
sepsis [86]. Bcl-2 is a mitochondrial protein that counteracts apoptotic processes. 
However, in the inflammatory phase of sepsis, some apoptosis of neutrophils is 
necessary [87].
Changed erythrocyte features have been reported in sepsis, such as the thorny 
erythrocytes called echinocytes [88] and increased RDW [89]. Reports have also 
claimed RDW to be of prognostic value in sepsis [90], but this has not been con-
firmed in other studies [91]. Erythrocytes seem to experience oxidative stress in 
sepsis [88, 89, 92]. Malondialdehyde, a product of lipid peroxidation, was increased 
by 3-fold in erythrocytes of sepsis patients [92]. Peroxynitrite has been reported as 
the major ROS in plasma of sepsis patients [88]. Sepsis patients often suffer from 
a moderate level of anemia [93]. Anemia in sepsis can have multiple causes such 
as anemia of chronic disease or hemolysis by bacterial toxins [43]. Hemolysis has 
often been reported in sepsis caused by Clostridium perfringens [94]. It is caused 
by disruption of the erythrocyte plasma membrane by phospholipase C activity of 
the Clostridium alpha-toxin [94]. A murine cecal ligation and puncture model of 
sepsis showed that sepsis is lethal in mice deficient for the heme-degrading enzyme 
heme oxygenase-1 [95]. The same study also showed that administration of the 
heme-sequestering protein hemopexin could prevent lethality. This suggests the 
importance of hemolysis in the pathogenesis of sepsis.
Sepsis can also be induced by virus [96]. For instance, COVID-19 and sepsis 
share similarities but also show some differences. Cytokine storm occurs in both 
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diseases, although more so in the early stages of sepsis [97]. Lymphopenia has been 
reported in Covid-19 and is a typical feature of the immunosuppressed later stage 
of sepsis. Activation of the coagulation cascade occurs in both diseases, including 
reports of disseminated intravascular coagulation [98]. Similarities in pathophysiol-
ogy implies that the same therapeutics may be relevant for both diseases. A murine 
model of sepsis based on cecal ligation and puncture recently showed increased 
survival with subcutaneous human interleukin-7 [99]. Positive results were later 
reported from a phase 2 clinical trial [100] of sepsis patients. Based on these results, 
interleukin-7 therapy has also been suggested for Covid-19 [97]. Interleukin-7 
stimulates hematopoietic stem cells to differentiate into the common lymphoid 
progenitor. The rationale for interleukin-7 therapy is therefore a rebalancing of 
lymphoid cells, which is implicated by lymphopenia in both diseases. Interleukin-7 
may also prevent apoptosis of immune cells [101]. Unfortunately, no approved 
sepsis-specific therapy exists despite many clinical trials.
7.  Protein interactions and signaling mechanisms of possible 
immunological relevance
Band3 is the most abundant protein of the erythrocyte plasma membrane. The 
function of band3 is the excretion of bicarbonate formed from CO2 by carbonic 
anhydrase. A chloride ion is simultaneously imported. The process is reversed 
in the lungs where CO2 is released. Band3 has been implicated in intracellular 
signaling based on its cytosolic N-terminal domain, which consists of the first 
360 of the 911 amino acid residues of the protein [30]. It was shown to interact 
with deoxyhemoglobin and enzymes of the glycolytic pathway. The much shorter 
C-terminal tail (amino acid residues 873–911) interacts with carbonic anhydrase 
II (CA) (Figure 4), forming a metabolon [102]. Band3 also interacts with ankyrin 
and spectrin [103], which stabilizes the band3 tetramer structure, calnexin during 
its maturation [30] and stomatin (Figure 4), which modulates the anion exchange 
activity of band3 [104]. Band3 often occurs in complex with glycophorin A presum-
ably contributing to stabilization of the band3 tetramer in the plasma membrane 
[30]. In stored blood, band3 was found to interact also with flotillin-2, alpha-
adducin and adenylosuccinate lyase [15].
Figure 4. 
Schematic figure of protein interactions and signaling mechanisms of the erythrocyte. Abbreviations are 
explained in the text.
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A connection between blood coagulation and the immune system was shown by 
the finding that macrophages produce tissue factor, a transmembrane protein that 
starts the extrinsic coagulation cascade [105]. A connection between erythrocytes 
and coagulation is suggested by a correlation between decreased hematocrit and 
longer bleeding times. Erythrocytes receive signals in the form of lysophosphatidic 
acid and prostaglandin E2 from activated platelets [106] (Figure 4). Increasing 
cytosol calcium concentration then increases interaction forces between erythro-
cytes, thereby contributing to thrombus formation [107]. Increasing intracellular 
calcium levels also lead to phosphatidylserine exposure on the plasma membrane 
of the erythrocyte (Figure 4). Phosphatidylserine then acts as a binding surface 
for gamma-carboxyglutamyl residues of the vitamin K-dependent carboxylation/
gamma-carboxyglutamic (Gla) domains of coagulation factors [108] (Figure 4). 
This initiates the formation of thrombin from prothrombin [109]. Contribution 
to coagulation also comes from erythrocyte micro-vesicles that similarly expose 
phosphatidylserine on the surface. However, erythrocyte micro-vesicles negatively 
regulate coagulation by supporting activated Protein C [110].
Erythrocytes respond to adenosine nucleotides by the adenosine tri-phosphate 
(ATP)-gated P2X and P2Y cation channel receptors in the erythrocyte plasma mem-
brane. ATP is released from erythrocytes in an autocrine or paracrine mechanism of 
action in response to bacterial exotoxins called hemolysins [111]. They are produced 
by many bacteria and display several mechanisms of action. Alpha-hemolysin of 
Escherichia coli cause an increase in cellular calcium levels and opening of potassium 
and chloride ion channels [112]. ATP release then occurs either through pannexin 
channels (Figure 4) or through pores formed by hemolysins in the erythrocyte 
plasma membrane [111]. The subsequent activation of P2X receptors leads to 
exposure of phosphatidylserine on the surface of erythrocytes, making possible 
clearance by macrophages. Phosphatidylserine exposure can be prevented by P2X 
receptor blockers [112]. Purinergic signaling may be a way to avoid the damaging 
effects of intravascular hemolysis that would result without phosphatidylserine 
exposure and subsequent clearance by macrophages [112].
8. Senescence, aging, eryptosis and hemolysis of the erythrocyte
The erythrocyte has an average lifespan of around 120 days. As erythrocytes age 
they become less deformable, shrink in size and display dysfunctional hemoglobin 
accumulations. Calcium regulation may be part of what determines erythrocyte 
lifespan (Figure 5). Normally calcium concentrations are much lower in erythrocyte 
cytosol than in the surrounding fluid. During erythrocyte aging, intracellular levels 
of calcium increase. The events leading to this increase are not fully understood. 
One proposed mechanism is activation of the mechanosensitive PIEZO1 ion channel 
[113] through decreased deformability of the aging erythrocyte (Figure 5). PIEZO1 
is a rather unspecific ion channel and can therefore cause general dissipation of ion 
gradients. In the case of calcium this would mean higher intracellular concentra-
tion. Gradually dysfunctional plasma membrane calcium efflux channels may also 
contribute to the higher calcium levels. Higher intracellular calcium concentrations 
are known to activate the Gardos channel, a potassium efflux channel in the plasma 
membrane involved in the regulation of cell volume in erythrocytes (Figure 5) and 
some other cells. Activation of the Gardos channel leads to potassium export and 
concomitant loss of water and chloride, together known as the Gardos effect. As 
they grow older, erythrocytes accordingly become more dehydrated. Support for this 
also comes from mutations in PIEZO1 [113] and the Gardos channel.
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The sequence of events from dehydration to erythrocyte clearance from circula-
tion have not been fully elucidated. In one recently proposed model, erythrocytes 
may respond to dehydration by shedding Glycophorin C-containing vesicles, 
thereby losing membrane sialic acid [13]. Less sialic acid would result in activation 
of the basal cell adhesion molecule (BCAM, also known as Lutheran antigen) and 
CD44 membrane proteins of the erythrocyte. Ligands of BCAM and CD44 are 
laminin-alpha-5 and hyaluronan (Figure 5), known as parts of the extracellular 
matrix. Binding to laminin-alpha-5 or hyaluronan could possibly delay erythrocyte 
passage through spleen and liver making encounters with macrophages and clear-
ance from circulation more likely.
Activation of the Gardos channel and dehydration are thus effects of increased 
erythrocyte calcium levels. Another consequence of increased calcium levels is 
phosphatidylserine exposure on the erythrocyte plasma membrane (Figure 5). This 
effect is likely to occur because of calcium-caused activation of scramblase, a mem-
brane enzyme that equilibrates membrane lipids between the two plasma membrane 
leaflets. Further to this effect, calcium inactivates flippase, a membrane enzyme that 
moves lipids from the outer plasma membrane to the inner plasma membrane leaflet. 
Exposed phosphatidylserine can then bind to several phosphatidylserine receptors 
exposed on phagocytic cells [114], facilitating clearance of erythrocytes from circu-
lation by spleen or liver macrophages. In young and healthy cells, phosphatidylserine 
occurs mainly on the inner leaflet of the plasma membrane. Exposure of phosphati-
dylserine is a marker for cell stress and effectively functions as an “eat-me” signal.
Yet another contribution to erythrocyte aging comes from the membrane protein 
CD47, a heavily glycosylated protein with five transmembrane domains and an extra-
cellular N-terminal immunoglobulin-like domain (Figure 5). CD47 is a “don’t eat 
me” signal that protects the cell from being phagocytosed by macrophages or other 
phagocytes. CD47 binds the macrophage signal-regulatory protein alpha (SIRP-
alpha), a transmembrane protein with three immunoglobulin-like extracellular 
domains. CD47-SIRP-alpha interaction leads to phosphorylation of immunorecep-
tor tyrosine-based inhibition (ITIM) motifs in the cytoplasmic tail of SIRP-alpha. 
This leads to the recruitment of Src homology phosphatases (SHP) preventing 
Figure 5. 
Schematic figure of senescence, aging, eryptosis and hemolysis of the erythrocyte. Abbreviations are explained 
in the text.
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myosin-IIA accumulation and phagocytosis by the macrophage. As erythrocytes 
grow older they display less CD47 on their surfaces, thereby increasing the likelihood 
for being eaten by macrophages. However, the role of CD47 in erythrocyte clearance 
may not be limited to a reduced “do not eat me” signal. CD47 can also bind thrombo-
spondin-1, a multifunctional protein of the extracellular matrix. Evidence suggests 
that conformational changes in CD47, perhaps caused by oxidation as the cell ages, 
promotes binding of thrombospondin. The resulting complex then instead becomes 
an “eat me” signal when binding to SIRP-alpha of the macrophage [115].
Senescence and aging has been suggested to be regulated through band3 acting 
as a “molecular clock” for the erythrocyte [116]. Partial proteolysis, oxidation, 
phosphorylation and binding of methemoglobin or hemichrome to band3 leads to 
protein clustering and conformational changes that are recognized by anti-band3 
autoantibodies (Figure 5). Binding of C3 complement then leads to phagocytosis 
of the aging erythrocyte when it encounters red pulp spleen or liver macrophages 
(Figure 5). Presumably, antibodies and complement must reach a threshold of 
opsonization for clearance by macrophages to take place. An appealing aspect 
of this “clock” is that it gauges the content of dysfunctional hemoglobin inside 
each erythrocyte, thus weeding out erythrocytes that have become unacceptably 
dysfunctional in their crucial role as oxygen carriers. If erythrocytes are ruled by a 
“clock”, another candidate is the period circadian protein homolog 2 (PER2) of the 
circadian clock, a physiological system that determines the biological day-length of 
the organism. Erythrocytes of PER2-deficient mice showed morphological changes 
and impaired oxygen transport [117].
Eryptosis is the regulated cell death associated with erythrocytes. Eryptosis can 
be induced by oxidative stress, pathogen infection, certain diseases like sepsis and 
sickle-cell disease and certain drugs and chemicals. Eryptosis can also be protected 
against by several means, notably some plant-derived substances like ascorbate, 
caffeine and resveratrol [118]. Signaling leading to eryptosis involves ceramide, 
prostaglandin E2 and increased intracellular calcium levels. Similar to what happens 
in senescence and aging, this induces scramblase and inhibits flippase leading to 
phosphatidylserine exposure on the plasma membrane. Eryptosis is largely seen as 
a means for the organism to avoid the serious consequences of hemolysis and may 
even prevent pathogen growth [118]. Still, phosphatidylserine receptors on vascular 
endothelial cells can bind eryptotic erythrocytes leading to impaired microcircula-
tion [119]. Regulation of eryptosis involves several kinases like the p21-activated 
kinase PAK2 and mitogen-and stress-activated kinase MSK1/2 [119]. Experiments 
with knock-out mice further suggested involvement of the beta-glucosidase-like 
protein Klotho. In healthy human and mice, Klotho is a co-receptor for fibroblast 
growth factor 23, regulating phosphate metabolism and vitamin-D synthesis. 
Klotho deletion ultimately leads to premature aging and death. Whether Klotho is 
involved in regulation of physiological eryptosis in humans remains unknown.
Both eryptosis and senescence involve erythrocyte-macrophage interactions. 
The close interactions between erythrocytes and macrophages follow through-
out the erythrocyte lifespan. To begin with, macrophages participate in erythropoi-
esis, the formation and development of erythrocytes in the erythroblastic islands 
of the bone marrow. During the lifetime of the erythrocyte, passage through spleen 
and liver generates new macrophage encounters. In these encounters erythrocytes 
are screened for healthiness and may be repaired by the macrophages [120], for 
instance by removal of the inclusion bodies containing damaged hemoglobin, called 
Heinz bodies. Erythrocytes are the main source of blood MIF1 (macrophage migra-
tion inhibitory factor 1), although the physiological significance of this remains to 
be established [8]. At last, the senescent or eryptotic erythrocyte is phagocytosed by 
spleen or liver macrophages.
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Hemolysis is the lysis of erythrocytes and release of their cellular contents in sur-
rounding fluids. Intravascular hemolysis occurs mainly as a consequence of bacterial 
infection and production of endotoxins. Hemolysis may also occur as a consequence 
of shear stress when erythrocytes pass through narrow capillaries. The mechanism 
underlying hemolysis is overhydration due to defective ion efflux channels, particu-
larly sodium/potassium ATPase. Cell volume increase will lead to rupture of the cell 
membrane and release of cytosolic contents. Hemolysis is typical of some diseases 
such as sickle-cell disease or glucose-6-phosphate deficiency. The fate of hemoglobin 
is an important aspect of hemolysis. Free hemoglobin typically binds to haptoglobin 
and the complex is then internalized through binding to the CD163 receptor on 
macrophages (Figure 5). If this does not occur, and if the iron has been oxidized to 
the ferric Fe(III) state, plasma hemoglobin will be separated into globin and heme. 
Being hydrophobic, free heme makes contact to plasma proteins such as albumin, 
alpha-1 antitrypsin, alpha-2 macroglobulin, lipoproteins and hemopexin. Binding to 
hemopexin effectively sequesters heme, making the complex largely safe for further 
circulation in the vascular compartment. The complex will eventually be internalized 
through binding to the low density lipoprotein receptor-related protein 1 (LRP1) 
receptor (Figure 5) on hepatocytes or macrophages [121]. If bound to albumin, 
heme can be transported into cells by binding to transferrin receptor 1. If cellular 
uptake does not happen by these routes, for instance due to hemopexin saturation, 
free heme can contribute to inflammation by binding the TLR4 receptor (Figure 5). 
Heme is in this context acting as a danger-associated molecular pattern (DAMP). 
Since TLR4 occurs also on endothelial cells, the vasculature is able to directly 
respond to increased heme levels. The effect of TLR4 stimulation is activation of 
NF-kB (nuclear factor kappa-light-chain-enhancer of activated B cells), inflamma-
some activation leading to activation of caspase-1 and release of pro-inflammatory 
interleukins like interleukin-1-beta, and interleukin-18. Recently, binding of heme 
to TLR4 was shown to be dependent on myeloid differentiation factor 2 (MD-2) and 
the glycosylphosphatidyl inositol (GPI)-anchored leucine-rich repeat protein CD14 
[122]. As a comparison, in eryptosis and normal senescence and aging, macrophages 
typically phagocytose the whole erythrocyte and free heme does not appear.
Heme can also activate the alternative pathway of complement, and activate 
platelets through C-type-lectin-like receptor 2 [123]. In sickle cell disease patients 
and murine models of sickle-cell disease, hemolysis caused kidney deposits con-
sisting of complement C3. The condition was probably caused by heme activation 
of complement, since it was possible to counteract by addition of hemopexin 
[124]. Free heme and its iron is available for use by bacterial pathogens and this is 
considered as an important aspect of hemolysis, for instance in hemolytic anemia. 
Sequestering of heme and hemoglobin is thus an important protection against 
damage caused by hemolysis. Inside the cell, heme is catabolized by heme oxy-
genase-1, producing biliverdin, free iron and carbon monoxide. The expression 
of heme oxygenase-1 can be induced by heme relieving gene repression through 
the BACH-1 heme-sensing repressor (Figure 5). The net effect of the catabolism is 
largely anti-inflammatory due to lower levels of TNF-alpha, interleukin-1-beta, and 
macrophage inflammatory protein (MIP) and upregulation of interleukin-10 [125]. 
The carbon monoxide produced as a by-product may however contribute to oxida-
tive stress due to reactions with reduced transition metals [125]. Heme oxygenase-1 
is itself a heme-containing enzyme of the heat shock protein family, present in the 
endoplasmic reticulum membrane oriented to the cytosol and expressed through-
out the body (Figure 5). The globin part of hemoglobin is regarded as largely non-
inflammatory [3]. Heme and its consequences are the most well-studied aspects of 
hemolysis. Less well-studied effects of hemolysis include release of intracellular or 
surface-bound cytokines from erythrocytes.
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9. Some genetic diseases particularly relevant in the erythrocyte context
Glucose-6-phosphate dehydrogenase is an enzyme in the glycolysis and pen-
tose phosphate pathways. Its deficiency particularly effects the erythrocyte since 
the erythrocyte depends on glycolysis and the pentose phosphate pathway for 
its energy needs. Erythrocyte irregularities called Heinz bodies are frequent in 
glucose-6-phosphate deficiency. The deficiency is particularly common in sub-
Saharan Africa due to a survival advantage in malaria-afflicted areas. Interestingly, 
deficiency for glucose-6-phosphate dehydrogenase seems to be associated with 
hemolysis in Covid-19 patients [126]. Patients with glucose-6-phosphate deficiency 
may react with hemolysis as a response also to other infections and treatment 
with primaquine or hydroxychloroquine [127, 128], suggesting a more general 
susceptibility to hemolysis associated with glucose-6-phosphate deficiency. Some 
other diseases involving the erythrocyte are sickle-cell disease, thalassemia, 
stomatocytosis, spherocytosis, ovalocytosis, paroxysmal nocturnal hemoglobinuria 
(PNH), polycythemia vera, acute erythroid leukemia and lecithin-cholesterol 
acyltransferase deficiency (LCAT). Paroxysmal nocturnal hemoglobinuria (PNH) 
is an intravascular hemolytic anemia, most often caused by somatic mutations in 
the gene encoding phosphatidylinositol glycan A (PIGA), leading to dysfunctional 
GPI-dependent anchoring of membrane proteins. One such erythrocyte membrane 
protein is decay accelerating factor (DAF) which acts to limit action of the alterna-
tive complement pathway. The resulting complement-driven hemolysis can be 
counteracted by the humanized monoclonal antibody eculizumab directed against 
terminal complement component C5.
10. Outlook for new treatments and diagnosis
The Duffy antigen may be of diagnostic value for some diseases, particularly 
malaria, but may perhaps also prove to be a druggable target, since G-protein 
coupled receptors are among the most common drug targets. The signaling 
mechanisms discovered recently particularly regarding band3 may also be of 
pharmacological interest. The mechanism underlying eryptosis may be used to kill 
off infected erythrocytes [129]. It is known that antioxidants like ascorbic acid and 
catechin, provided through the diet can have protective effects on the erythrocyte. 
Refined erythrocyte related diet recommendations could perhaps be expected. The 
erythrocyte has previously been used in various physical or biochemical ways as 
a diagnostic tool. Such tests are the erythrocyte sedimentation rate, hematocrit, 
erythrocyte distribution width, erythrocyte count, mean corpuscular hemoglobin 
concentration and mean corpuscular volume. New diagnostic or treatment devel-
opments can be expected based on molecular, biotechnological and genetic tech-
niques. One example would be ICP-MS to detect element profile changes of genetic, 
epigenetic or environmental origin.
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